Source: Rheum Dis Clin North Am 2002 May;28(2):379-87 Martinez-Lavin M. Instituto Nacional de Cardiologia, National Autonomous University of Mexico, Juan Badiano 1, 14080 Mexico City DF, Mexico. email@example.com
The realization of dysautonomia in FM has opened the possibility for new and different therapeutic interventions. Much more research is needed to better define the role of ANS in the pathogenesis of FM. If this research supports current hypotheses, therapeutic trials with disciplines and substances intended to correct autonomic dysfunction will be indicated.
PMID: 12122925 [PubMed – in process]